This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55 ...

While patients with Parkinson’s initially start taking oral drugs like levodopa and carbidopa ... patients who cannot have apomorphine, with a list price of £84.70 per vial ahead of discounts.

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Researchers have developed an AI system that predicts chemical compounds capable of targeting two proteins simultaneously, ...

A new study shows that a common glaucoma drug cleared tau build-up and reduced signs of neurodegenerative disease in zebrafish and mice.

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

A new study finds poor attention spans in childhood, plus certain genes, could play a role in raising the risk for psychosis, ...

Amantadine may help relieve Parkinson’s symptoms or treat drug-induced movement problems ... This may not be a complete list of medicines that can interact with amantadine.